Srinivasan College of Pharmaceutical Sciences, Samayapuram, Trichy.
To evaluate the anti-asthmatic activity of Euphorbia hirta through pharmacological assessment and phytochemical screening. The research focuses on identifying bioactive compounds responsible for its medicinal properties and scientifically validating its efficacy. The study involves the collection and authentication of Euphorbia hirta, followed by extraction using the Soxhlet apparatus with ethanol. Pharmacognostical analysis, including macroscopic and microscopic studies, was conducted to identify the plant’s physical and anatomical characteristics. Phytochemical screening was performed to detect the presence of alkaloids, flavonoids, saponins, terpenoids, tannins, steroids, amino acids, and volatile oils. The chemical composition was further analyzed using Gas Chromatography-Mass Spectrometry (GC-MS). In vitro anti-asthmatic activity was assessed through cell viability assays using THP-1 cell lines. The pharmacognostical analysis confirmed the morphological and anatomical features of Euphorbia hirta. Phytochemical screening indicated the presence of several bioactive compounds with potential therapeutic benefits. GC-MS analysis identified key chemical constituents. In vitro studies demonstrated the plant extract's anti-inflammatory and anti-asthmatic effects, supporting its traditional use in respiratory ailments. The findings validate the anti-asthmatic potential of Euphorbia hirta, highlighting its efficacy in treating respiratory disorders. The presence of bioactive compounds suggests its potential as a natural alternative for asthma management. Further in vivo studies and clinical trials are recommended to establish its therapeutic applications.
Euphorbia hirta, commonly known as the “asthma plant,” is a medicinal herb renowned in traditional medicine for its diverse health benefits, particularly in managing respiratory ailments like asthma. This is also known as the Australian asthma herb or Queensland asthma weed, spurge or milkweed. This small, green, bushy plant and it is a common weed found throughout the hotter parts of India and most of the tropical and subtropical countries It is frequently seen occupying open waste spaces, grasslands, roadsides, pathways and is often dismissed as a weed. Euphorbia plants are characterized by the presence of milky latex, which they exude when broken. The extract of Euphorbia hirta has a sedative effect on the mucous membrane of the respiratory and genitourinary tracts. The whole plant also has been reported to possess anti-asthmatic, antiinflammatory, anti-bacterial, anti-amoebic, antifungal, antiviral, spasmolytic, anti-diarrheal, anxiolytic, analgesic, anti-pyretic, anti-malarial, and anti-hypertensive properties. Euphorbia hirta Linn has been long utilized as an herbal medicine globally in remedying and curing many infections and diseases in humans. Euphorbia hirta is especially notable for its role in treating respiratory conditions such as asthma, bronchitis and other lung-related ailments. A putative species has been known for its medicinal, cultural and ethnobotanical uses. In India, the plant parts are traditionally used to treat worm infestations in babies and for dysentery, gonorrhea, jaundice, acne, pimples, digestive disorders, cancer, diabetes and different tumors. The extracts of the root are used against vomiting and diarrhea and for snakebite as an anti-venom. It is not toxic when taken in typical dosages. The effectiveness of E. hirta in treating asthma may lie predominantly in the synergistic relationships between the flavonoids, sterols and triterpenoids. The medicinal usefulness of this herb has been the subject of numerous chemical and microbiological studies. According to the WHO estimates, Since 1970s, the global prevalence, morbidity, mortality and economic burden of asthma have increased particular in children released in December 2016, there were 3,83,000 deaths due to asthma in 2015. Asthma is an obstructive pulmonary disease with different etiologies, affecting approximately 300 million people worldwide. By 2025, a further 100 million will be added to this estimate. The plants medicinal use dates back centuries, with historical records from different continents documenting its therapeutic roles. (FIG. 1)
Fig.1 The Figure Shows the Whole Plant of Euphorbia Hirta
1.1. Plant Profile
Synonym
Asthma Weed, Snake Weed, Hairy Spurge, Ara Tanath
Biological Source
It consists of fresh and dried whole plant of Euphorbia hirta Linn
Family Euphorbiaceae
Geographical Source
India
Taxonomical Classification
|
Kingdom |
Plantae |
|
Subkingdom |
Viridiplantae |
|
Division |
Tracheophyta |
|
Subdivision |
Spermatophytina |
|
Class |
Magnoliopsida |
|
Order |
Malpighiales |
|
Family |
Euphorbiaceae |
|
Genus |
Euphorbia |
|
Species |
Euphorbia hirta |
Botanical Source
Leaves
• The leaves are simple with a very short petiole and are arranged oppositely distichous. These may be green or red in color and sometimes with a purple blotch on the adaxial side. Both sides of the leaf are covered with sparsely appressed pubescent. A white latex flow when cut.(FIG.2)
• The blade is lanceolate-oblong, long elliptic, or ovate-lanceolate in shape. Its base is asymmetric, having obliquely rounded on one side and cuneate on the other side. In addition, the apex is acute and the margin is serrate to serrulate. The venation is trinerved at the base. It has 3–5 pairs of lateral veins arising at the base or slightly above the base initiated along the blade.
Fig. 2 The Figure Shows the Leaves of Euphorbia Hirta
Flowers
Fig. 3 The Figure Shows the Flowers of Euphorbia Hirta
Fruits And Seeds
Fig. 4 The Figure Shows the Fruits and Seeds of Euphorbia hirta
Stem
Fig. 5 The Figure Shows the Stem of Euphorbia hirta
Root
Fig. 6 The Figure Shows the Root of Euphorbia hirta
Medicinal Uses
Fig. 7 The Figure Shows the Medicinal Uses of Euphorbia hirta
1.2. Asthma
The National Institute of Health defines asthma as a chronic inflammatory disorder of airways in which cellular elements play a major role particularly mast cells, T-lymphocytes, eosinophils, epithelial cells and neutrophils. Asthma is a life-threatening, enduring respiratory disorder, resulting in the inflammation and narrowing of airways. Exacerbation includes bronchospasm, edema, mucus secretion, cellular infiltration and damage of the airway epithelium. Asthma is associated with wheezing, breathlessness, chest tightness, and coughing brought about by inflammation, bronchial constriction, and excessive mucus secretion due to bronchial hyper-responsiveness. 10 % of asthma sufferers are children and 5% are adults. (FIG.8). Asthma mortality in the United States amounted to some 5000 persons in the year 2000. The global prevalence of the disease is expected to rise to 400 million by the year 2025. Most of the available pharmacological therapies simply control the known mechanisms by which the disease occurs; there is no complete cure for asthma. Pharmaceutical products have been the main source of Anti-asthma treatment, but some of these have recently been associated with serious adverse effects. The increased number of asthma patients in every country led to drug unavailability, expensive drug prices and exorbitant. In India, Ayurveda is a traditional practice of medicinal plants in the treatment of asthma that is considered to be natural and safe (TABLE.1 & 2)
Table.1. Classification
|
Characteristics
|
Intermittent |
|
Persistent |
|
|
Mild |
Moderate |
Severe |
||
|
Daytime symptoms |
<2/week |
3-4 week |
>4/month |
Continuous |
|
Nocturnal symptoms |
<1/month |
2-4/month |
>4/ month |
Frequent |
|
PEFR (predicted) |
>80% |
>80% |
60-80% |
<60% |
Fig. 8 The Figure Shows the Human Normal and Asthmatic Lung
Table.2. To Determine the Human Lung Without and With Asthma
|
Lung Without Asthma |
Lung With Asthma |
|
Muscle relaxed |
Muscle tightens |
|
Normal airways |
Airways swell |
|
Normal amount of mucus |
Mucus clogs the airways |
Mechanism Of Action
Asthma is well known to have a high level of IgE that binds to the receptors of mast cells and inflammatory products. The interaction between antigen and antibody IgE results in the activation of an inflammatory cellular reaction. Thereby releasing the mediators, such as histamine and prostaglandins, that ultimately lead to the contraction of airway smooth muscles. Asthma can be triggered by various factors such as viral respiratory infections, certain chemicals, certain medications, airborne allergens, occupational sensitizers, smoke, air pollutants, stress, anxiety or extreme emotional arousal, may also trigger asthmatic attacks. (FIG.9)
Fig. 9 The Figure Shows the Mechanism of Action for Asthma
Pathways
1. Extrinsic asthma
2. Intrinsic asthma
1.Extrinsic asthma
It is caused by allergic responses to such things as house dust, animal fur, or various foods. Such cases account for about 10 to 20%.
2.Intrinsic asthma
It is caused by genetic and structural problems and infection. Both physiological and psychological. Such cases account for about 50–60%.
Causes
Asthma can develop when the body’s defence system reacts strongly to a new substance in the lungs. Asthma usually develops during childhood (called childhood asthma) and some people do not show signs of asthma until adulthood (adulthood asthma). Many factors like allergens in the environment, viral infections, and family history work together to develop asthma.
Symptoms
Symptoms of asthma occur intermittently and last for about a few hours to days. These symptoms resolve when the triggers are removed or with the administration of medications.
Common asthma signs and symptoms
Severe asthma symptoms
Symptoms of severe asthma are often persistent, and these symptoms are observed at least once a day.
Medical Condition
Those who are suffering from eczema or hay fever is on high risk of developing asthma.
Diagnosis
The test can be done during spirometry or with a small handheld device.
2. MATERIALS AND METHODS
? Pharmacognostical Studies
? Invitro Studies
MTT Assay Using THP – 1 Cell Line
2.1 Source of The Plant Material
Synonym
Asthma Weed, Snake Weed. Hairy Spurge, Ara Tanath,
Family
Euphorbiaceae
Vernacular Names
Geographical Source
2.2 Collection of the Plant Material
The Plant Euphorbia hirta Linn was collected from Lalgudi in Tiruchirapalli District, and Authenticated by Prof. Dr. V. Nandhagopalan, Head of the Department of Botany, National College, Trichy.
2.3 Extraction
Preparation Of Plant Powder
Preparation Of the Ethanolic Extract
Fig.10 The Figure Shows the Identification of Extract of Crude Drug
2.4 Pharmacognostical Studies
Macroscopic Studies
The Macroscopy was carried out to determine the Nature of the plant, Organoleptic Properties (Colour, Odour, Taste, Size, Shape and Extra features) of the Whole Plant.
Leaves
Flowers
Fruits
Seed
Stem
Root
Extra Features
Leaves - Elliptic-oblong to oblong-lanceolate, acute or subacute
Flowers - Male flowers-sessile, with linear bracteoles, solitary stamen, are fringed and lack a perianth. Female flowers-a short pedicel, superior ovary, ringed perianth, three styles threecelled, minute, and two- fid apex hair
Fruits - three-celled, hairy, keeled capsules, containing three brown, four-sided, angular, wrinkled seeds
Seeds - Four-sided, without caruncle, slightly wrinkled.
Stem - Smooth, slender, densely branched, hairy stems & posseses 2-3 internodes.
Root - Arranged in a taproot system
Microscopic Studies
Transverse Section of Leaf (Fig.11)
Nodal anatomy
One median and two lateral leaf traces are observed in the nodal region with three leaf gaps for a leaf. Node is trilacunar three trace.
Lamina
Midrib
Midrib has parenchymatous ground tissue except adaxial region where palisade cells of lamina are extended. A single large roundish collateral strand is present in the center, which is completely or partially encircled by latex cells.
Petiole
Petiole has parenchymatous ground tissue and three small collateral vascular bundles arranged in a crescentic manner. Scattered latex cells are present in the ground tissue of petiole. Trichomes similar to the stem are present in lamina, midrib and petiole.
Fig.11. The Figure Shows Transverse Section of Leaf
A-Node, B- Lamina with midrib, C- Surface view of epidermis of lamina D- Petiole (Mit- median leaf trace, lit- lateral leaf trace, lc- latex cell, as- anomocytic stomata).
Transverse Section of Stem (FIG.12)
In young stem 16 - 18 collateral vascular bundles are observed in a ring. Pith is made up of parenchyma cells. Pericycle is formed by alternate groups of fibers and parenchyma cells. Epidermis is consisted of small rectangular or tubular cells on which a thick and wavy cuticle is present. Hypodermis of collenchyma is observed below epidermis Epidermal surface is covered by large number of Glandular, multicellular, uniseriate, filiform, cylindrical and bent trichomes.Stem has cortex of 6 - 8 layers. Scattered latex cells are present in the cortical region in old stem secondary vascular tissues are produced. Secondary xylem has solitary vessel elements or found arranged in radial groups of 2 - 4. Xylem fibers are abundant and xylem rays are uni- biseriate.
Fig.12 The Figure Shows Transverse Section of Stem (Lc-latex cell, Co-collenchyma, Ux- Uniseriate xylem rays)
Transverse Section of Root (Fig. 13)
It is composed of cortex of 4 - 6 layers of parenchyma and tetrarch xylem. Rarely xylem is diarch. Pith is scanty or absent. Vascular cambium forms larger amount of thick walled, polygonal or rectangular fibres, roundish, angular, solitary vessel elements and uniseriate rays. The secondary phloem appears deformed or compressed.
Fig.13 The Figure Shows Transverse Section of Root (xf- xylem fibres, ux- uniseriate xylem rays, pd- phelloderm, sp- secondary phloem)
2.5 Phytochemical Screening (Fig.14)
Test For Alkaloids
Wagner’s test:
2ml of plant extract was taking, 3-5 drops Wagner’s reagent was added, and the formation of Reddish-brown precipitate or coloured was observed.
Test For Saponins
Foam test:
Take 2 ml of extract and 5ml distilled water and shake vigorously. Observe for the formation of Persistent foam for 10-15 minutes that confirms the presence of saponins.
Test For Flavonoids
Alkaline reagent test:
2 ml of plant extract was taken and treated it with 3-5 drops of 20% sodium hydroxide solution. Observe for formation of intense yellow colour, which becomes colourless on addition of 0.5ml dilute Hcl indicates presence of flavonoids
Test For Terpenoids
Take 2 ml of plant extract, treat it with 0.5ml of conc. HCl, and indicate for the formation of yellow precipitate or coloration.
Test For Tannins
Braymer’s Test:
Take 2 ml of extract, treat it with 1ml of 10% Alcoholic Ferric Chloride solution, and observe for the formation greenish colour.
Test For Steriods
Add 2 mL of extract to 2 mL of chloroform and 2 mL of concentrated H2SO4. A reddish colour indicates steroids.
Test For Amino Acids
Million’s Test:
Take 2 ml of extract, add 5 drops of Million’s reagent, and warm the mixture in boiling water bath for 10 minutes. Cool to room temperature and add 5 drops of Sodium Nitrate solution. Observe the Brick red colour it indicates the presence of Amino acids.
Test For Volatile Oils
Take 2 ml of extracts, 0.5 ml of dilute NaOH and small amount of dilute HCl acid were added and the formation of white precipitates indicates volatile oils.
Test For Carbohydrates
Take 2ml of extracts in a test tube, add 2 drops of 1% α 1- naphthol, mix and then allow 2ml of conc. Sulphuric acid to flow down the side of the inclined tube to layer under the mixture.
Test For Proteins
Biuret Test:
Take 2ml of the extract, egg albumin and deionised water in the test tube. Add 2ml of biuret reagent to the test tube. Shake well and allow the mixtures to stand for 5 minutes. Observe no colour change that is solution remains blue proteins are not present.
Fig.14 The Figure Shows the Qualitative Phytochemical Screening
2.6 Analytical Studies
Gas Chromatography/Mass Spectrometry (Gc/Ms) Analysis
The extract of plant was tested by chromatography–mass spectrometer analysis to detect and quantify the components using GC ultra-system from Thermo Fisher Scientific, Waltham, MA, USA, fitted with a 30 m × 0.25 mm × 0.25 m Elite-5-MS capillary column, and was used to analyze the extracts. The temperature of the column during the analysis was raised at a rate of 4 °C/min from 40 °C to 220 °C. The injection volume of 1 μL was maintained at the injector temperature of 250 °C; the transfer temperature was maintained at 280 °C and at the flow rate of 20 mL/min, with helium as the carrier gas. The following MS settings were used: EI mode, 70 eV for the ionization voltage, a range of scan of 50–600 Da, and 180 °C for the ion source temperature. Tentative identification of the peaks was achieved based on a library search using Wiley Registry 8 Edition and NIST. (GRAPH.1)
Graph.1. Gas Chromatography/Mass Spectrometry (GC/MS) Analysis
2.7 Invitro Studies
Cell Culture and Differentiation of Thp-1 Cell Line (Starr Et Al. 2018)
THP-1 cells were obtained from NCCL, Pune. Cells were cultured in (RPMI-1640) medium accompanied with 10% complement-inactivated fatal bovine serum (FBS), 100 IU/mL penicillin, 100 μg/mL streptomycin, and 3.7 g sodium bicarbonate/L (Sigma-Aldrich,). In order to activate THP-1 (4x104) cells to differentiate, cells were cultured in 96-multi-well culture plates, then 100 ng/mL of phorbol 12-myristate 13-acetate was added. Cells were washed with RPMI-1640 serumfree medium prior to each experiment to remove undifferentiated cells. For activation of macrophage-like cells, cells were then treated with LPS (100 ng/mL) for 24 h.
Analysis Of Cell Viability (MTT Assay)
Cell viability was measured by MTT assay. THP-1 cells were exposure to different concentrations (5 to 100 µg/mL) of crude extract. Briefly, media was replaced with 50 µL/well serum-free media and 50 µL/well MTT reagents. Cells were cultured in 24-well plates and incubated for three hours. Optical density (OD) was measured at 590 nm using a microplate reader (Spectra Max). All experiments were performed in triplicate. (FIG.15).
Fig.15 The Figure Shows MTT Assay
3. RESULT
Extraction Yield
The Ethanolic extract of Euphorbia hirta yielded 2.76%.
Pharmacognostical Studies
Macroscopical Studies
The macroscopy was carried out to determine the nature of the plant.
Organoleptic properties of the whole plant was identified.
Microscopical Studies
The Microscopical characters was presented the transverse section of stem, leaf, root
Phytochemical Screening
The chemical constituents present are Alkaloids, Saponins, Flavonoids, Terpenoids, Tannins, Steroids, Amino acids, Volatile oils, Carbohydrates, Proteins (TABLE.3)
Table.3 Qualitative Phytochemical Screening
|
S. No |
Test |
Result |
|
1. |
Alkaloids |
Positive |
|
2. |
Saponins |
Positive |
|
3. |
Flavonoids |
Positive |
|
4. |
Terpenoids |
Positive |
|
5. |
Tannins |
Positive |
|
6. |
Steriods |
Positive |
|
7. |
Amino Acids |
Positive |
|
8. |
Volatile Oils |
Positive |
|
9. |
Carbohydrates |
Negative |
|
10. |
Proteins |
Negative |
Gas Chromotography/Mass Spectrometry
GC/MS method is used qualitative identification quantitative measurement of individual components in a complex mixture. (TABLE.4)
Table.4 Nist Library Matched Compounds
|
Peak |
Retention Time |
Area % |
Height |
Height % |
Name |
|
1. |
37.781 |
46.37 |
29878 |
37.55 |
(13Z)-13-DOCOSENAMIDE |
|
2. |
37.835
|
10.68
|
10218 |
12.84 |
CESIUM TRIMETHYLFLUORO)ALUM INATE |
|
3. |
37.89 |
3.8 |
5988 |
7.54 |
CYCLOPENT-2-EN-1,4-DION |
|
4. |
39.077 |
12.24 |
4741 |
5.96 |
PROCYMIDONE |
|
5. |
39.259 |
5.78
|
4687 |
5.89 |
4-TERT-BUTYL-3,4- DIHYDRO-2,4- DIPHENYLQUINAZOLINE |
|
6. |
39.322 |
3.76 |
4795 |
6.03 |
TRICARBONYL [(1- 4(.ELATA.)-5-(2-AMINO-5- METHOXY-3,4DIMETHYLPHENYL)-1,3CYCLOHEXADIENE]IRON |
|
7. |
39.375 |
4.47 |
4805 |
6.04 |
4-TERT-BUTYL-3,4- DIHYDRO-2,4- DIPHENYLQUINAZOLINE |
|
8. |
39.403 |
4.78 |
5099 |
6.41 |
4,4'- BIS(PHENYLTELLURO)AZO BENZENE |
|
9. |
39.48
|
5.25 |
4792 |
6.02 |
4-TERT-BUTYL-3,4DIHYDRO-2,4- DIPHENYLQUINAZOLINE |
|
10. |
39.611 |
2.88 |
4573 |
5.75 |
4-TERT-BUTYL-3,4DIHYDRO-2,4- DIPHENYLQUINAZOLINE |
In Vitro Anti-Asthmatic Activity (Table.5 & 6) (Graph.2) (Fig.16)
Table.5 MTT Assay Table.5 Statistical Analysis of Cell Proliferation For 24h
|
24H |
1 |
2 |
3 |
Statistics On Rows of B: D |
% viability |
|
|
|
|
|
|
Mean |
Standard Deviation |
|
|
C |
0.7 |
0.72 |
0.7 |
0.70666667 |
0.0094281 |
100 |
|
DMSO |
0.68 |
0.66 |
0.66 |
0.66666667 |
0.0094281 |
5.660377358 |
|
5 |
0.68 |
0.68 |
0.66 |
0.67333333 |
0.0094281 |
4.716981132 |
|
10 |
0.58 |
0.58 |
0.6 |
0.58666667 |
0.0094281 |
16.98113208 |
|
25 |
0.54 |
0.56 |
0.52 |
0.54 |
0.0163299 |
23.58490566 |
|
50 |
0.5 |
0.51 |
0.5 |
0.50333333 |
0.004714 |
28.77358491 |
|
100 |
0.46 |
0.44 |
0.,42 |
0.45 |
0.01 |
36.32075472 |
Table.6 Statistical Analysis of Cell Proliferation For 48h
|
48H |
1 |
2 |
3 |
Statistics On Rows of B: D |
% viability |
|
|
|
|
|
|
Mean |
Standard Deviation |
|
|
C-LPC |
0.78 |
0.76 |
0.72 |
0.75333333 |
0.02494438 |
100 |
|
DMSO |
0.72 |
0.74 |
0.72 |
0.72666667 |
0.00942809 |
3.539823009 |
|
5 |
0.64 |
0.62 |
0.62 |
0.62666667 |
0.00942809 |
16.81415929 |
|
10 |
0.52 |
0.54 |
0.54 |
0.53333333 |
0.00942809 |
29.20353982 |
|
25 |
0.52 |
0.5 |
0.56 |
0.52666667 |
0.02494438 |
30.08849558 |
|
50 |
0.45 |
0.49 |
0.48 |
0.47333333 |
0.01699673 |
37.16814159 |
|
100 |
0.4 |
0.38 |
0.38 |
0.38666667 |
0.00942809 |
48.67256637 |
Graph.2. Percentage Of Cell Viability
Fig 16 The Figure Shows Microscopic Image of Cell Proliferation
4. DISCUSSION
Pharmacognostical Studies
The Macroscopical and Microscopical studies of Euphorbia hirta revealed detailed morphological and anatomical characteristics of the plant. The leaves, stem, and root were examined, and their structural features were documented. The presence of latex cells, trichomes, and specific vascular arrangements were noted.
Phytochemical Screening
The Qualitative phytochemical analysis confirmed the presence of various bioactive compounds, including alkaloids, saponins, flavonoids, terpenoids, tannins, steroids, amino acids, and volatile oils. These compounds are known for their therapeutic properties, particularly in managing respiratory disorders. The presence of flavonoids and terpenoids is particularly significant, as these compounds are often associated with anti-asthmatic effects.
GC/MS Analysis
The Gas Chromatography-Mass spectrometry (GC/MS) analysis identified several compounds in the ethanolic extract of Euphorbia hirta. Compounds such as (13Z)-13-Docosenamide and Cyclopent-2-en-1, 4-dion were detected, which may contribute to the plant's medicinal properties. These compounds have been linked to anti-inflammatory and anti-asthmatic activities, supporting the traditional use of Euphorbia hirta in treating respiratory conditions.
In Vitro Anti-Asthmatic Activity
The MTT assay was conducted to evaluate the anti-asthmatic activity of Euphorbia hirta extract on THP-1 cells. The results showed a dose-dependent reduction in cell viability, indicating potential anti-inflammatory and anti-asthmatic effects. The extract's ability to inhibit cell proliferation suggests that it may help reduce inflammation in the airways, a key factor in asthma management.
5. CONCLUSION
The study examined the leaves, stem, and root of Euphorbia hirta, documenting key features like latex cells, trichomes, and vascular arrangements, which help in identifying and standardizing the plant for medicinal use. Phytochemical screening revealed the presence of bioactive compounds such as alkaloids, flavonoids, terpenoids, and steroids, known for their anti-asthmatic effects, with flavonoids and terpenoids being particularly important for respiratory health. GC/MS analysis identified compounds like (13Z)-13-Docosenamide and Cyclopent-2-en-1, 4dion, which are linked to anti-inflammatory and anti-asthmatic properties, supporting the traditional use of Euphorbia hirta for respiratory conditions. Additionally, the MTT assay demonstrated that the plant extract reduces cell viability in a dose-dependent manner, suggesting its potential to reduce airway inflammation, a key factor in asthma, and highlighting its promise as a natural treatment for asthma. Further research, are necessary to develop formulations for asthma management.
REFERENCES
Dhanapal V, Samuel TB, Muddukrishniah K and Vijayan S (2018) Screening of Euphorbia hirta extracts for antioxidant activity.
Dhanapal V, Samuel TB, Muddukrishniah K and Vijayan S (2018) Screening of Euphorbia hirta extracts for antioxidant activity.
Swathi E., Sowmiya B., Vishwa Raja V., Nivetha S. R., Mohamed Thaiyub B., A. Bal Prijith*, Anti -Asthmatic Activity of An Ethanolic Extract of Entire Plant of Euphorbia Hirta from the Pharmacognostical, Pharmacological and Phytochemical Screening - An Research, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 8, 254-279. https://doi.org/10.5281/zenodo.16735602
10.5281/zenodo.16735602